Article
NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer
24 Aug 2018
Abstract excerpt
Abstract The key negative regulatory gene of the RAS pathway, NF1 , is mutated or deleted in numerous cancer types and is associated with increased cancer risk and drug resistance. Even though women with neurofibromatosis (germline NF1 mutations) have a substantially increased breast cancer risk at a young age and NF1 is commonly mutated in sporadic breast cancers, we have a limited understanding of the role of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
